Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CSIINYSE:LGVNASDAQ:OFIXNASDAQ:SIBN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCSIICardiovascular Systems$20.00$19.98$12.26▼$20.57$843.96M0.74765,906 shs4,300 shsLGVLongview Acquisition Corp. II$10.09$10.09$9.68▼$10.15N/AN/AN/AN/AOFIXOrthofix Medical$11.28$13.34$10.50▼$20.73$441.96M0.87270,643 shs306,203 shsSIBNSI-BONE$18.86-0.6%$15.62$11.70▼$20.05$803.72M0.82378,083 shs437,967 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCSIICardiovascular Systems0.00%0.00%0.00%0.00%0.00%LGVLongview Acquisition Corp. II0.00%0.00%0.00%0.00%0.00%OFIXOrthofix Medical0.00%+1.62%-18.91%-35.10%-21.94%SIBNSI-BONE-0.63%+2.61%+38.17%+4.08%+39.39%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCSIICardiovascular SystemsN/AN/AN/AN/AN/AN/AN/AN/ALGVLongview Acquisition Corp. IIN/AN/AN/AN/AN/AN/AN/AN/AOFIXOrthofix Medical3.0842 of 5 stars3.53.00.00.01.53.31.3SIBNSI-BONE3.8696 of 5 stars2.53.00.03.34.12.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCSIICardiovascular Systems 0.00N/AN/AN/ALGVLongview Acquisition Corp. II 0.00N/AN/AN/AOFIXOrthofix Medical 3.00Buy$23.33106.86% UpsideSIBNSI-BONE 3.00Buy$22.5019.30% UpsideCurrent Analyst Ratings BreakdownLatest SIBN, OFIX, CSII, and LGV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2025SIBNSI-BONETruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$20.00 ➝ $22.005/6/2025SIBNSI-BONECantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$25.00 ➝ $25.005/6/2025SIBNSI-BONENeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$24.00 ➝ $24.00(Data available from 5/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCSIICardiovascular Systems$239.84M3.52N/AN/A$6.12 per share3.27LGVLongview Acquisition Corp. IIN/AN/AN/AN/AN/AN/AOFIXOrthofix Medical$804.53M0.55N/AN/A$16.11 per share0.70SIBNSI-BONE$176.60M4.55N/AN/A$4.18 per share4.51Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCSIICardiovascular Systems-$36.93M-$0.97N/AN/AN/A-15.79%-15.39%-11.93%N/ALGVLongview Acquisition Corp. IIN/AN/A0.00∞N/AN/AN/AN/AN/AOFIXOrthofix Medical-$151.40M-$3.69N/AN/AN/A-15.18%-21.25%-13.29%8/5/2025 (Estimated)SIBNSI-BONE-$43.34M-$0.64N/AN/AN/A-23.82%-22.51%-16.53%8/4/2025 (Estimated)Latest SIBN, OFIX, CSII, and LGV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2025Q1 2025SIBNSI-BONE-$0.24-$0.15+$0.09-$0.15$45.13 million$47.29 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCSIICardiovascular SystemsN/AN/AN/AN/AN/ALGVLongview Acquisition Corp. IIN/AN/AN/AN/AN/AOFIXOrthofix MedicalN/AN/AN/AN/AN/ASIBNSI-BONEN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCSIICardiovascular Systems0.086.044.92LGVLongview Acquisition Corp. IIN/AN/AN/AOFIXOrthofix Medical0.252.391.11SIBNSI-BONE0.228.257.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCSIICardiovascular Systems86.61%LGVLongview Acquisition Corp. IIN/AOFIXOrthofix Medical89.76%SIBNSI-BONE98.11%Insider OwnershipCompanyInsider OwnershipCSIICardiovascular Systems3.80%LGVLongview Acquisition Corp. II26.35%OFIXOrthofix Medical1.30%SIBNSI-BONE4.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCSIICardiovascular Systems78042.20 million40.59 millionOptionableLGVLongview Acquisition Corp. II3N/AN/ANot OptionableOFIXOrthofix Medical1,09039.18 million37.22 millionOptionableSIBNSI-BONE35042.62 million40.30 millionOptionableSIBN, OFIX, CSII, and LGV HeadlinesRecent News About These Companies15,454 Shares in SI-BONE, Inc. (NASDAQ:SIBN) Bought by Man Group plcMay 29 at 3:48 AM | marketbeat.comSI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025May 28 at 4:30 PM | globenewswire.comSI-BONE’s SWOT analysis: stock poised for growth amid market expansionMay 28 at 12:00 AM | investing.comWall Street Analysts See a 34.22% Upside in Si-Bone (SIBN): Can the Stock Really Move This High?May 26, 2025 | zacks.comNuveen Asset Management LLC Has $17.72 Million Stake in SI-BONE, Inc. (NASDAQ:SIBN)May 26, 2025 | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) Shares Bought by Lazard Asset Management LLCMay 23, 2025 | marketbeat.comNorthern Trust Corp Increases Holdings in SI-BONE, Inc. (NASDAQ:SIBN)May 23, 2025 | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) Shares Acquired by Paradigm Capital Management Inc. NYMay 22, 2025 | marketbeat.comVirtus Investment Advisers Inc. Acquires Shares of 13,950 SI-BONE, Inc. (NASDAQ:SIBN)May 21, 2025 | marketbeat.comInsider Selling: SI-BONE, Inc. (NASDAQ:SIBN) CFO Sells 2,424 Shares of StockMay 21, 2025 | insidertrades.comSilvercrest Asset Management Group LLC Boosts Position in SI-BONE, Inc. (NASDAQ:SIBN)May 19, 2025 | marketbeat.comMercer Global Advisors Inc. ADV Invests $210,000 in SI-BONE, Inc. (NASDAQ:SIBN)May 19, 2025 | marketbeat.comGraham Capital Management L.P. Invests $498,000 in SI-BONE, Inc. (NASDAQ:SIBN)May 18, 2025 | marketbeat.comSI-BONE, Inc. (NASDAQ:SIBN) CFO Anshul Maheshwari Sells 4,937 SharesMay 17, 2025 | marketbeat.comInsider Selling: SI-BONE, Inc. (NASDAQ:SIBN) CFO Sells 4,937 Shares of StockMay 16, 2025 | insidertrades.comParkman Healthcare Partners LLC Acquires 31,284 Shares of SI-BONE, Inc. (NASDAQ:SIBN)May 16, 2025 | marketbeat.comDimensional Fund Advisors LP Has $4.97 Million Holdings in SI-BONE, Inc. (NASDAQ:SIBN)May 15, 2025 | marketbeat.comSI-BONE (NASDAQ:SIBN) Sets New 12-Month High - What's Next?May 14, 2025 | marketbeat.com4 Recent Earnings Winners Riding Fresh Momentum in May (SIBN)May 14, 2025 | marketbeat.comWhat Makes Si-Bone (SIBN) a Strong Momentum Stock: Buy Now?May 13, 2025 | zacks.comSchonfeld Strategic Advisors LLC Takes $426,000 Position in SI-BONE, Inc. (NASDAQ:SIBN)May 13, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSIBN, OFIX, CSII, and LGV Company DescriptionsCardiovascular Systems NASDAQ:CSIICardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.Longview Acquisition Corp. II NYSE:LGVLongview Acquisition Corp. II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on businesses in the healthcare, industrials, consumer, media, technology, and technology services sector. The company was incorporated in 2020 and is based in New York, New York.Orthofix Medical NASDAQ:OFIX$11.28 0.00 (0.00%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$11.36 +0.09 (+0.75%) As of 05/30/2025 04:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.SI-BONE NASDAQ:SIBN$18.86 -0.12 (-0.63%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$18.89 +0.03 (+0.13%) As of 05/30/2025 04:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell Ackman Takes a Swing at Amazon — Should You? Taiwan Semiconductor: Time to Buy After Strong NVIDIA Results? Intel’s Turnaround May Be the Best Bet No One’s Watching Nike’s Amazon Expansion Could Signal a Turnaround in 2025 ASML Stock Might Be the Safest Chip Play at This Price Archer Aviation Stock Steadies After Short-Seller Report Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
